Results 11 to 20 of about 984,354 (150)

IL-38 promotes the development of prostate cancer [PDF]

open access: yesFrontiers in Immunology
IntroductionProstate Cancer (PCa) remains a significant concern in male cancer-related mortality. Tumour development is intricately regulated by the complex interactions between tumour cells and their microenvironment, making it essential to determine ...
Huiyan Wu   +9 more
doaj   +4 more sources

The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases [PDF]

open access: yesFrontiers in Pharmacology, 2021
Interleukin-38 (IL-38), a new cytokine of interleukin-1 family (IL-1F), is expressed in the human heart, kidney, skin, etc. Recently, new evidence indicated that IL-38 is involved in the process of different autoimmune diseases. Autoimmune diseases are a
Miao-miao Han   +12 more
doaj   +5 more sources

IL-38: A New Player in Inflammatory Autoimmune Disorders [PDF]

open access: yesBiomolecules, 2019
Interleukin (IL)-38, a newly discovered IL-1 family cytokine, is expressed in several tissues and secreted by various cells. IL-38 has recently been reported to exert an anti-inflammatory function by binding to several receptors, including interleukin-36
Lihui Xie   +5 more
doaj   +6 more sources

The role of IL-38 in intestinal diseases - its potential as a therapeutic target [PDF]

open access: yesFrontiers in Immunology, 2022
IL-38, an anti-inflammatory cytokine, is a key regulator of homeostasis in host immunity. Intestinal immunity plays a critical role in defence against pathogenic invasion, as it is the largest surface organ and the most common entry point for micro ...
Qiang Wang   +4 more
doaj   +2 more sources

Role of IL-38 and Its Related Cytokines in Inflammation [PDF]

open access: yesMediators of Inflammation, 2015
Interleukin- (IL-) 38 is a recently discovered cytokine and is the tenth member of the IL-1 cytokine family. IL-38 shares structural features with IL-1 receptor antagonist (IL-1Ra) and IL-36Ra. IL-36R is the specific receptor of IL-38, a partial receptor
Xianli Yuan   +3 more
doaj   +4 more sources

Recombinant IL-38 Alleviates Temporomandibular Joint Synovial Inflammation via IL-1R1-NF-κB-IL1β Pathway [PDF]

open access: yesInternational Dental Journal
Introduction and aims: Interleukin (IL)-38 has been identified as an anti-inflammatory cytokine; however, its specific role in temporomandibular joint (TMJ) synovial inflammation and the identity of its functional receptors remain elusive.
Ping Luo   +3 more
doaj   +2 more sources

Role of IL-1 Family Cytokines IL-36, IL-37, IL-38 in Osteoarthritis and Rheumatoid Arthritis: A Comprehensive Review [PDF]

open access: yesJournal of Inflammation Research
Yuan Xu, Jing-Yan Wang, Yang Zou, Xue-Wei Ma, Tian Meng College of Health Industry, Sichuan Tourism University, Chengdu, Sichuan, 610100, People’s Republic of ChinaCorrespondence: Yuan Xu, Email 230973159@qq.comAbstract: Inflammatory cytokines ...
Xu Y, Wang JY, Zou Y, Ma XW, Meng T
doaj   +2 more sources

IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome [PDF]

open access: yesMediators of Inflammation, 2021
Interleukin- (IL-) 38 is an emerging cytokine with multiple functions involved in infection and immunity. However, the potential role of IL-38 in the host immune response during sepsis remains elusive.
Yun Ge   +4 more
doaj   +2 more sources

IL-35, IL-37, and IL-38 in acute pancreatitis: proposed immunopathogenic mechanisms and therapeutic potential [PDF]

open access: yesFrontiers in Immunology
Acute pancreatitis (AP) is driven by premature enzyme activation, pancreatic tissue injury, and dysregulated immune responses. IL-35 and IL-37 are key anti-inflammatory mediators whose dynamic regulation influences disease severity.
Hailong Yan   +6 more
doaj   +2 more sources

Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes [PDF]

open access: yesFrontiers in Immunology
IntroductionColorectal cancer (CRC) presents a substantial challenge characterized by unacceptably high mortality and morbidity, primarily attributed to delayed diagnosis and reliance on palliative care.
Liuhong Yuan   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy